Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Fosun International Limited    0656   HK0656038673

FOSUN INTERNATIONAL LIMITED (0656)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Fosun International : Voluntary Announcement – Preparation to Establish a Life Insurance Joint Venture Company

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2011 | 11:55am CEST

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

VOLUNTARY ANNOUNCEMENT PREPARATION TO ESTABLISHA LIFE INSURANCE JOINT VENTURE COMPANY

The Board is pleased to announce that Fosun Industrial Technology, a wholly owned subsidiary of the Company and The Prudential Insurance Company of America, the United States insurance arm of Prudential Financial, Inc., have recently received a formal approval from the China Insurance Regulatory Commission on preparation to establish a life insurance joint venture company in China.

The board of directors (the “Board”) of Fosun International Limited (the “Company”) is pleased to announce that Shanghai Fosun Industrial Technology Development Company Limited (“Fosun Industrial Technology”), a wholly owned subsidiary of the Company and The Prudential Insurance Company of America, the United States insurance arm of Prudential Financial, Inc., an independent third party of the Company, have recently received a formal approval from the China Insurance Regulatory Commission on preparation to establish a life insurance joint venture company in China (the “Transaction”).

The life insurance joint venture company will start with a registered capital of RMB500 million with The Prudential Insurance Company of America and Fosun Industrial Technology each contributing 50 percent of it. The joint venture company is proposed to be headquartered in Shanghai.

The Board believes that China’s insurance business has great growth potential and the

Transaction fits into the long-term investment strategy of the Company.

The Transaction is conducted in the ordinary and usual course of business of the Company and does not constitute a notifiable transaction nor a connected transaction for the Company under Chapter 14 or Chapter 14A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

By Order of the Board Fosun International Limited Guo Guangchang

Chairman

Shanghai, the PRC, 15 September 2011

As at the date of this announcement, the executive directors of the Company are Mr. Guo Guangchang, Mr. Liang Xinjun, Mr. Wang Qunbin, Mr. Fan Wei, Mr. Ding Guoqi, Mr. Qin Xuetang and Mr. Wu Ping; the non- executive director is Mr. Liu Benren; and the independent non-executive directors are Dr. Chen Kaixian, Mr. Zhang Shengman and Mr. Andrew Y. Yan.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FOSUN INTERNATIONAL LIMITE
05/25Sunvision, AECOM team up on transit-oriented development
AQ
05/25FOSUN INTERNATIONAL : Fashion Group Makes Bold Changes In Leadership At St. John..
AQ
05/25Sunvision, AECOM team up on transit-oriented development
AQ
05/24Buru Energy - Oil Focused Canning Basin Transactions Strengthen Balance Sheet..
AQ
05/23AAG ENERGY : in talks for potential offer by Fosun's unit
AQ
05/21FOSUN INTERNATIONAL : Huge Chinese Conglomerate Fosun Eyes North America for New..
AQ
05/18FOSUN INTERNATIONAL : Int'l raises stake in Folli Follie to 16.37%
AQ
05/17FOSUN INTERNATIONAL : Voluntary announcement
PU
05/15SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma to form JV for maternal and infant ..
AQ
05/15Manipal, TPG swoop in with sweetened bid for India's Fortis
RE
More news
News from SeekingAlpha
04/08WEEK IN REVIEW : Concord Medical Raises $240 Million For China Radiology Service.. 
03/28Fosun International, Ltd. 2017 Q4 - Results - Earnings Call Slides 
03/25WEEK IN REVIEW : James Watson To Lead New Shenzhen Biopharma Research Center 
03/04WEEK IN REVIEW : Grail Plans $500 Million Hong Kong IPO For Cancer Diagnostics 
02/25WEEK IN REVIEW : Taiwan Liposome Files For $50 Million Secondary IPO In The U.S. 
Financials ( CNY)
Sales 2018 95 315 M
EBIT 2018 2 084 M
Net income 2018 14 129 M
Debt 2018 74 365 M
Yield 2018 2,21%
P/E ratio 2018 7,95
P/E ratio 2019 7,24
EV / Sales 2018 2,04x
EV / Sales 2019 1,85x
Capitalization 120 B
Chart FOSUN INTERNATIONAL LIMITE
Duration : Period :
Fosun International Limite Technical Analysis Chart | 0656 | HK0656038673 | 4-Traders
Technical analysis trends FOSUN INTERNATIONAL LIMITE
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 20,5  CNY
Spread / Average Target 46%
EPS Revisions
Managers
NameTitle
Qun Bin Wang Chief Executive Officer & Director
Qi Yu Chen Co-President & Executive Director
Xiao Liang Xu Co-President & Executive Director
Guang Chang Guo Chairman
Can Wang Chief Financial Officer, Executive Director & SVP
Sector and Competitors
1st jan.Capitalization (M$)
FOSUN INTERNATIONAL LIMITED-0.81%18 803
ARCELORMITTAL5.05%34 113
POSCO--.--%28 025
NIPPON STEEL & SUMITOMO METAL CORP-19.70%20 544
NUCOR1.62%20 349
THYSSENKRUPP-2.46%16 739